242 related articles for article (PubMed ID: 27284726)
1. Long-term Outcomes of MRI Stage IIB Cervical Cancer.
Yoon A; Park JJ; Park BK; Lee YY; Paik ES; Choi CH; Kim TJ; Kim CK; Lee JW; Bae DS; Kim BG
Int J Gynecol Cancer; 2016 Sep; 26(7):1252-7. PubMed ID: 27284726
[TBL] [Abstract][Full Text] [Related]
2. Postoperative outcomes of MR-invisible stage IB1 cervical cancer.
Park JY; Lee JW; Park BK; Lee YY; Choi CH; Kim TJ; Bae DS; Kim BG; Park JJ; Park SY; Kim CK
Am J Obstet Gynecol; 2014 Aug; 211(2):168.e1-7. PubMed ID: 24607752
[TBL] [Abstract][Full Text] [Related]
3. Treatment outcomes in patients with FIGO stage IB-IIA cervical cancer and a focally disrupted cervical stromal ring on magnetic resonance imaging: A propensity score matching study.
Kong TW; Lee JD; Son JH; Paek J; Chun M; Chang SJ; Ryu HS
Gynecol Oncol; 2016 Oct; 143(1):77-82. PubMed ID: 27423377
[TBL] [Abstract][Full Text] [Related]
4. Preoperatively Assessable Clinical and Pathological Risk Factors for Parametrial Involvement in Surgically Treated FIGO Stage IB-IIA Cervical Cancer.
Canaz E; Ozyurek ES; Erdem B; Aldikactioglu Talmac M; Yildiz Ozaydin I; Akbayir O; Numanoglu C; Ulker V
Int J Gynecol Cancer; 2017 Oct; 27(8):1722-1728. PubMed ID: 28617687
[TBL] [Abstract][Full Text] [Related]
5. Parametrial involvement in FIGO stage IB1 cervical carcinoma diagnostic impact of tumor diameter in preoperative magnetic resonance imaging.
Kamimori T; Sakamoto K; Fujiwara K; Umayahara K; Sugiyama Y; Utsugi K; Takeshima N; Tanaka H; Gomi N; Takizawa K
Int J Gynecol Cancer; 2011 Feb; 21(2):349-54. PubMed ID: 21721193
[TBL] [Abstract][Full Text] [Related]
6. The value of MRI in quantification of parametrial invasion and association with prognosis in locally advanced cervical cancer: the "PLACE" study.
Russo L; Pasciuto T; Lupinelli M; Urbano A; D'Erme L; Amerighi A; Fanfani F; Scambia G; Manfredi R; Sala E; Ferrandina G; Gui B
Eur Radiol; 2024 Jun; 34(6):4003-4013. PubMed ID: 37981591
[TBL] [Abstract][Full Text] [Related]
7. Comparison of laparoscopic versus abdominal radical hysterectomy for FIGO stage IB and IIA cervical cancer with tumor diameter of 3 cm or greater.
Kong TW; Chang SJ; Lee J; Paek J; Ryu HS
Int J Gynecol Cancer; 2014 Feb; 24(2):280-8. PubMed ID: 24407571
[TBL] [Abstract][Full Text] [Related]
8. Development of criteria for ovarian preservation in cervical cancer patients treated with radical surgery with or without neoadjuvant chemotherapy: a multicenter retrospective study and meta-analysis.
Hu T; Wu L; Xing H; Yang R; Li X; Huang K; Jia Y; Zhang Q; Chen Z; Wang S; Liu D; Han X; Lin Z; Qu P; Cai H; Song X; Tian X; Wang H; Wang S; Xie X; Li S; Ma D
Ann Surg Oncol; 2013 Mar; 20(3):881-90. PubMed ID: 23054110
[TBL] [Abstract][Full Text] [Related]
9. Apparent diffusion coefficient for prediction of parametrial invasion in cervical cancer: a critical evaluation based on stratification to a Likert scale using T2-weighted imaging.
Woo S; Kim SY; Cho JY; Kim SH
Radiol Med; 2018 Mar; 123(3):209-216. PubMed ID: 29058233
[TBL] [Abstract][Full Text] [Related]
10. Primary uterine cervical cancer: correlation of preoperative magnetic resonance imaging and clinical staging (FIGO) with histopathology findings.
Kraljević Z; Visković K; Ledinsky M; Zadravec D; Grbavac I; Bilandzija M; Soljacić-Vranes H; Kuna K; Klasnić K; Krolo I
Coll Antropol; 2013 Jun; 37(2):561-8. PubMed ID: 23941005
[TBL] [Abstract][Full Text] [Related]
11. [Wertheim-operation: 5-year survival of 501 consecutive patients with cervical cancer].
Papp Z; Csapó Z; Mayer A; Hupuczi P
Orv Hetil; 2006 Mar; 147(12):537-45. PubMed ID: 16696377
[TBL] [Abstract][Full Text] [Related]
12. Outcome of international Federation of gynecology and obstetrics stage IIb cervical cancer from 2003 to 2012: an evaluation of treatments and prognosis: a retrospective study.
Guo L; Liu X; Wang L; Sun H; Huang K; Li X; Tang F; Li S; Yuan X; Wang C
Int J Gynecol Cancer; 2015 Jun; 25(5):910-8. PubMed ID: 25867278
[TBL] [Abstract][Full Text] [Related]
13. Impact of laparoscopic radical hysterectomy on survival outcome in patients with FIGO stage IB cervical cancer: A matching study of two institutional hospitals in Korea.
Kim SI; Lee M; Lee S; Suh DH; Kim HS; Kim K; Chung HH; No JH; Kim JW; Park NH; Song YS; Kim YB
Gynecol Oncol; 2019 Oct; 155(1):75-82. PubMed ID: 31383569
[TBL] [Abstract][Full Text] [Related]
14. Radical hysterectomy for FIGO stage IIB cervical cancer: clinicopathological characteristics and prognostic evaluation.
Kasamatsu T; Onda T; Sawada M; Kato T; Ikeda S
Gynecol Oncol; 2009 Jul; 114(1):69-74. PubMed ID: 19398126
[TBL] [Abstract][Full Text] [Related]
15. A volumetric analysis of GTV
Jastaniyah N; Yoshida K; Tanderup K; Lindegaard JC; Sturdza A; Kirisits C; Šegedin B; Mahantshetty U; Rai B; Jürgenliemk-Schulz IM; Haie-Meder C; Banerjee S; Pötter R;
Radiother Oncol; 2016 Sep; 120(3):404-411. PubMed ID: 27452409
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Parametrial Response by Growth Pattern in Patients With International Federation of Gynecology and Obstetrics Stage IIB and IIIB Cervical Cancer: Analysis of Patients From a Prospective, Multicenter Trial (EMBRACE).
Yoshida K; Jastaniyah N; Sturdza A; Lindegaard J; Segedin B; Mahantshetty U; Rai B; Jürgenliemk-Schulz I; Haie-Meder C; Sasaki R; Pötter R
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):788-96. PubMed ID: 26530747
[TBL] [Abstract][Full Text] [Related]
17. Platinum-based neoadjuvant chemotherapy followed by radical surgery for cervical carcinoma international federation of gynecology and obstetrics stage IB2-IIB.
Minig L; Colombo N; Zanagnolo V; Landoni F; Bocciolone L; Cárdenas-Rebollo JM; Iodice S; Maggioni A
Int J Gynecol Cancer; 2013 Nov; 23(9):1647-54. PubMed ID: 24100590
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic Factors of Cervical Adenocarcinoma Stages IB to IIB.
Mabuchi Y; Yahata T; Kobayashi A; Tanizaki Y; Shiro M; Ota N; Yagi S; Minami S; Ino K
Int J Gynecol Cancer; 2015 Nov; 25(9):1677-82. PubMed ID: 26495760
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological variables predictive of clinical outcome in patients with FIGO stage Ib2-IIb cervical cancer treated with cisplatin-based neoadjuvant chemotherapy followed by radical hysterectomy.
Gadducci A; Teti G; Barsotti C; Tana R; Fanucchi A; Orlandini C; Fabrini MG; Genazzani AR
Anticancer Res; 2010 Jan; 30(1):201-8. PubMed ID: 20150636
[TBL] [Abstract][Full Text] [Related]
20. Stage Ib, IIa, and IIb cervix cancer, postsurgical staging, and prognosis.
Matsuyama T; Inoue I; Tsukamoto N; Kashimura M; Kamura T; Saito T; Uchino H
Cancer; 1984 Dec; 54(12):3072-7. PubMed ID: 6498784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
